开展基于社区的正念减压与常规照护用于中重度偏头痛的随机对照预试验:正念与偏头痛研究(M&M)方案
本研究为在美国北加州开展的两臂平行对照单盲随机预试验,计划招募约60例中重度发作性偏头痛患者,比较8周社区正念减压课程联合常规照护与等待名单常规照护的可行性。可行性结局包括招募能力与时间、MBSR治疗依从性及使用31天头痛日记和患者报告问卷测量结局的能力。若预试验可行,将为基础性完整试验奠定基础。
要点
- 该预试验采用两臂平行对照单盲设计,计划招募约60例中重度发作性偏头痛患者。
- 干预组为8周社区正念减压课程联合常规照护,对照组为等待名单常规照护。
- 可行性结局包括招募能力与时间、MBSR依从性及31天头痛日记和问卷测量能力。
核心结论
- 若该预试验证明可行,作者计划开展完整试验以确定MBSR减少中重度发作性偏头痛患者头痛天数的有效性。
研究设计与样本
- 两臂平行对照单盲随机对照预试验,设于美国北加州,计划招募约60例中重度发作性偏头痛患者。
- 干预组为8周社区正念减压课程联合常规照护,等待名单对照组为常规照护。
- 可行性结局包括招募能力与所需时间、对MBSR治疗的依从性,以及使用31天头痛日记和患者报告问卷数据测量结局的能力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Migraine is one of the most common neurological disorders in clinical practice and is a substantial cause of disability worldwide. Current approaches to therapy are primarily based on medication but are often limited by inadequate effectiveness and common side effects. Newer, more effective medications are expensive. Mindfulness-based stress reduction (MBSR), an 8-week classroom-based meditation intervention, is inexpensive, has no known side effects, and has demonstrated clinically meaningful effectiveness for several chronic-pain syndromes. In addition, MBSR has shown promising results for migraine therapy in a few small case studies and pilot studies. We present here the protocol for a two-arm randomized controlled pilot trial of MBSR for moderate-to-severe episodic migraine, which, if successful, will form the basis for a fully powered clinical trial. METHODS/DESIGN: This study, set in Northern California, is a two-arm parallel-comparison single-blinded randomized controlled pilot trial with the goal of recruiting approximately 60 participants with moderate-to-severe episodic migraine. The feasibility outcomes include ability and time required to recruit, adherence to the MBSR treatment, and ability to measure outcomes using 31-day headache diaries and patient-reported questionnaire data. The active treatment arm consists of an 8-week community-based MBSR class plus usual care, and the wait-list control group is usual care. Recruitment is underway and expected to be complete by the end of 2018. DISCUSSION: To our knowledge, this is the first pragmatic trial in the U.S. of MBSR for migraine using community-based classes, and if it proves viable, we plan to conduct a fully powered trial to determine the effectiveness of the intervention for reducing headache days for moderate-to-severe episodic migraineurs. TRIAL REGISTRATION: Clinicaltrials.gov, NCT02824250 . Registered on 6 July 2016.
引用
- Pressman A, Law H, Stahl R, et al. Conducting a pilot randomized controlled trial of community-based mindfulness-based stress reduction versus usual care for moderate-to-severe migraine: protocol for the Mindfulness and Migraine Study (M&M). Trials. 2019. PMID: 31060619. doi:10.1186/s13063-019-3355-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。